Articles by tag: cancer-research

CD4+ T cells kill cancer through ferroptosis: a breakthrough in immunology

Scientists have proven: CD4+ T lymphocytes destroy MHC I-negative tumors through ferroptosis. The discovery changes the approach to cancer immunotherapy and treatment of GVHD. Read the details.

Genetically modified virus stopped pancreatic cancer: breakthrough

Oncolytic adenovirus from the University of Minnesota halted tumor growth in three patients with pancreatic cancer. Learn about the mechanism, risks, and prognosis.

Gene vgll3: mechanism of aging and cancer | Nature Communications

Discovery of the vgll3 gene confirms the theory of antagonistic pleiotropy: accelerated growth leads to aging and cancer. Learn about the implications for longevity research.

Proteomic Mapping of 28 Cancer Types: What You Need to Know

An international consortium has completed the first proteomic mapping of all 28 human cancer types. Learn about 13 new subtypes, targeted therapy, and the impact on oncology. Read more.

REVERT cancer therapy: a new concept or a marketing gimmick?

Analysis of the REVERT platform from KAIST: why turning cancer cells into normal cells is not news, but a PR tool. Read expert analysis and forecasts.

1700 new microproteins in DNA: a breakthrough in oncology

Scientists have found 1700+ microproteins in 'junk' DNA. Disabling 6 of them kills up to 85% of cancer cells. Find out how this will change cancer therapy.

Nanotechnology against cancer chemoresistance: a review from EUR J CANCER

Breakthrough in oncology: how nanoparticles and CRISPR epigenome editing reverse tumor resistance to chemotherapy. Learn about clinical successes in 2026.

Smart drugs for cancer and HIV: Russian development

Russian scientists are creating 'smart drugs' based on nucleic acids for targeted attack on cancer and HIV. Learn about the platform of the future and personalized medicine.